Industry News

Texas Tech dedicated the $22.8 million Terry Fuller Petroleum Engineering Research Building in Lubbock in February of 2014. Housing the Bob L. Herd Department of Petroleum Engineering, the 43,000-sf facility features integrated teaching and research labs, smart classrooms, a fracturing techniques suite, a fluids lab, a rheology lab, a pressure volume temperature lab, and a reservoir simulation center and drilling lab. The project was designed by Kirksey Architecture and built by Vaughn Construction.

Swansea University broke ground in spring of 2014 on the $13 million Data Science Building. Located on the Singleton Park Campus, the collaborative, interdisciplinary project will be constructed adjacent to the Institute of Life Sciences facilities that are slated for occupancy in fall of 2015. The 31,000-sf Data Science @ ILS will house the Centre for the Improvement of Population Health through e-Records Research (CIPHER), the Farr Institute of Health Informatics Research, and the Administrative Data Research Centre Wales (ADRC Wales).

The Jackson Laboratory (JAX) and the University of California, Davis have initiated a new phase in their ongoing research collaboration by sharing resources and core services. UC Davis will benefit from on-site educational programs at the JAX mouse facility in Sacramento, Calif. JAX will provide mouse colony management services for UC Davis investigators, expediting research discoveries by preventing transportation delays.

Michigan State University broke ground in spring of 2014 on the $730 million Facility for Rare Isotope Beams. Located in East Lansing, the project will be a national user facility for nuclear science research and is created in partnership with the Department of Energy. The first $165 million phase of construction includes a 227,000-sf building with extensive underground infrastructure to accommodate a superconducting linear accelerator. Completion is expected in 2018.

TNO Triskelion opened a BSL-3 vaccine testing laboratory in March of 2014 in Zeist. The facility will enable the contract research organization to develop drugs to combat viruses including avian influenza, SARS, and tuberculosis. The biocontainment lab conforms to GLP (Good Laboratory Practice) standards and is able to test treatments against all subtypes of influenza, whether avian or human.